E Lechler|H D Reuter|F Asbeck - JoVE Visualize

Showing results (21-30 of 35) with videos related to

Pageof 4

Sort By:

Journal of Natural Products|June 1, 1993

A novel amino acid glycoside and three amino acids from Allium sativumM Mütsch-Eckner, C A Erdelmeier, O Sticher, et al.

Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2012

Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double-blind study versus pyridoxineC Lauritzen, H D Reuter, R Repges, et al.

Deutsche Medizinische Wochenschrift (1946)|September 19, 1986

[Cyclophosphamide stosstherapy synchronized with plasmapheresis in rapidly progressive glomerulonephritis]H J Gutschmidt, H H Euler, J Albrecht, et al.

Deutsche Medizinische Wochenschrift (1946)|June 4, 1976

[Treatment of cardiogenic shock after acute myocardial infarction with intra-aortic balloon counterpulsation (author's transl)]K D Grosser, A Heller, F Asbeck, et al.

Thrombosis and Haemostasis|October 1, 1996

Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1R Schneppenheim, U Budde, S Krey, et al.

Klinische Wochenschrift|October 3, 1983

[Thrombopoiesis, thrombocyte count and thrombocyte function before and following cell separation]H Linker, H D Reuter, G Eckers, et al.

American Heart Journal|February 15, 2001

Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studiesB Frilling, R Schiele, A K Gitt, et al.

Thrombosis and Haemostasis|October 31, 1983

Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinaseW Theiss, F Asbeck, A Kriessmann, et al.

Cancer Research|September 1, 1985

Prevalence of antibodies to HTLV-III in AIDS risk groups in West GermanyV Erfle, R Hehlmann, W Mellert, et al.

Blut|October 1, 1985

Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood productsV Erfle, R Hehlmann, W Mellert, et al.

Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:

Pageof 4

Journal of Natural Products|June 1, 1993

A novel amino acid glycoside and three amino acids from Allium sativumM Mütsch-Eckner, C A Erdelmeier, O Sticher, et al.

Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2012

Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double-blind study versus pyridoxineC Lauritzen, H D Reuter, R Repges, et al.

Deutsche Medizinische Wochenschrift (1946)|September 19, 1986

[Cyclophosphamide stosstherapy synchronized with plasmapheresis in rapidly progressive glomerulonephritis]H J Gutschmidt, H H Euler, J Albrecht, et al.

Deutsche Medizinische Wochenschrift (1946)|June 4, 1976

[Treatment of cardiogenic shock after acute myocardial infarction with intra-aortic balloon counterpulsation (author's transl)]K D Grosser, A Heller, F Asbeck, et al.

Thrombosis and Haemostasis|October 1, 1996

Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1R Schneppenheim, U Budde, S Krey, et al.

Klinische Wochenschrift|October 3, 1983

[Thrombopoiesis, thrombocyte count and thrombocyte function before and following cell separation]H Linker, H D Reuter, G Eckers, et al.

American Heart Journal|February 15, 2001

Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studiesB Frilling, R Schiele, A K Gitt, et al.

Thrombosis and Haemostasis|October 31, 1983

Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinaseW Theiss, F Asbeck, A Kriessmann, et al.

Cancer Research|September 1, 1985

Prevalence of antibodies to HTLV-III in AIDS risk groups in West GermanyV Erfle, R Hehlmann, W Mellert, et al.

Blut|October 1, 1985

Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood productsV Erfle, R Hehlmann, W Mellert, et al.

Pageof 4